Helsinki, June 2025 — MVision AI, a global provider of AI-powered solutions for radiotherapy planning, has entered into a new distribution agreement with Active Medika, a Morocco-based provider of integrated medical infrastructure solutions. This partnership marks a significant step in expanding access to MVision AI’s technologies across North Africa.
This announcement follows the recent market approval of MVision AI’s Contour+ software by the Moroccan Agency for Medicines and Health Products (AMMPS), authorizing its use in clinical environments nationwide. With cancer now the second leading cause of death in Morocco, the integration of advanced radiotherapy tools such as Contour+ supports clinicians in managing growing demand for standardized, high-efficiency cancer care.
“As Morocco invests in modernizing its cancer care infrastructure, we see AI playing a vital role in supporting clinicians on the ground,” said Khalid Bougdid, Managing Director of Active Medika. “Our partnership with MVision AI ensures that radiotherapy departments across Morocco can benefit from tools that streamline workflows and align with clinical best practices.”
MVision AI’s solutions are centered around its GBS™ (Guideline-Based Segmentation) Suite, a unified platform for standardized, AI-supported contouring. The suite includes Contour+ for auto-contouring, Verify for contour comparison, and Guide for training and guideline familiarization. Together, these tools streamline radiotherapy workflows and promote consistency across clinics. MVision AI also recently introduced Dose+, an AI-guided plan optimization solution that delivers patient-specific dose predictions to support more efficient and consistent treatment planning.
“Our partnership with Active Medika is a timely opportunity to support Morocco’s healthcare professionals with clinically proven AI tools,” said Mahmudul Hasan, Executive Director and Founder of MVision AI. “With the market approval of Contour+ and a strong local partner in place, we’re positioned to deliver accessible, high-performance radiotherapy planning support across the region.”
Looking ahead, MVision AI and Active Medika are committed to further collaboration in order to expand clinical access, deliver hands-on support, and ensure that hospitals and cancer centers in Morocco can implement AI technologies with confidence and clarity.
About Active Medika
Active Medika is a Morocco-based provider of turnkey medical infrastructure solutions, offering a range of services and technologies for the design and implementation of healthcare environments. With a focus on radiology, oncology, and surgical infrastructure, Active Medika collaborates closely with clinical stakeholders to deliver projects that meet the highest operational and safety standards.
About MVision AI
MVision AI is a pioneering provider of AI-powered software for radiotherapy treatment planning. The company offers cloud-based tools that support same-day treatment planning through standardization and workflow automation. MVision AI’s solutions are trusted by clinics in over 20 countries and have supported the treatment of more than 200,000 cancer patients globally. Learn more at www.mvision.ai.